ID

18587

Description

A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT System Enrollment

Keywords

Versions (2)
  1. 11/2/16 11/2/16 -
  2. 11/11/16 11/11/16 -
Uploaded on

November 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

System Enrollment Galafold (migalastat) AT1001-012 NCT01218659

English

System Enrollment Galafold (migalastat) AT1001-012 NCT01218659

1 forms  
System Enrollment
Description

System Enrollment

Alias
UMLS CUI-1
C2348568
Subject number
Description

Subject number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Full subject number
Description

Full subject number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Back to the top of the page

Similar models

System Enrollment Galafold (migalastat) AT1001-012 NCT01218659

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
System Enrollment
C2348568 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Full subject number
Item
Full subject number
integer
C2348585 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial